Ledger.Open graph →
SEC Form D · Amendment · filed December 21, 2023

Allay Therapeutics, Inc

Offering
$86.9M
Sold
$86.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN JOSE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Paul A. Mccreadie · San Jose, CADirectorLeighton A. Read · San Jose, CADirectorAlexander Lewin · CAMBRIDGE, MADirectorMichael A. Carusi · San Jose, CADirectorAdam A. Gridley · San Jose, CAExec · DirectorMichael A. Carusi · San Jose, CADirectorLeighton A. Read · San Jose, CADirectorNicholas Van Eck · Jersey City, NJDirectorTak A. Cheung · San Jose, CADirectorAdam A. Gridley · San Jose, CAExec · DirectorPaul A. Mccreadie · San Jose, CADirectorMark A. Deem · San Jose, CADirectorNicole A. Vitullo · San Jose, CADirectorRyan D. Lepene · Chagrin Falls, OHExec · DirectorAndrew D. Evans · Jersey City, NJDirectorJosh A. Makower · San Jose, CADirectorNicole A. Vitullo · San Jose, CADirectorMark A. Deem · San Jose, CADirectorJosh A. Makower · San Jose, CADirectorF. H. Mandel · Chagrin Falls, OHDirectorTak A. Cheung · San Jose, CADirectorVasant K. Natarajan · Palo Alto, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗